Stijn Hentzen

5PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersPharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 28, 2023
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival.

Khalil Choucair, Caroline Nebhan, Alessio Cortellini

|Jul 17, 2023
Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy.

Stijn Hentzen, Kathan Mehta, Raed Moh'd Taiseer Al-Rajabi

|Jun 29, 2023
Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review.

Stijn Hentzen, Tomer Meirson, Kelly Koehn

|Nov 24, 2022
Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer.

Aviva Atri-Schuller, Hassan Abushukair, Ludimila Cavalcante

|Feb 25, 2022
Immunoglobin A Deficiency and Squamous Cell Carcinoma With a Rare Presentation as Anal Cancer.

Anup Kasi, Stijn Hentzen, Nikhil Gupta

Pageof 1

Frequent Collaborators

2 joint publications

Ludimila Cavalcante

1 joint publications

Hassan Abushukair

1 joint publications

Anwaar Saeed

1 joint publications

Ghulam Rehman Mohyuddin